Argan(US:AGX)2025-03-27 20:10Financial Performance - Consolidated revenues for Q4 2025 were $232.5 million, an increase of $67.9 million, or 41%, compared to $164.6 million in Q4 2024[8]. - For the fiscal year 2025, consolidated revenues were $874.2 million, an increase of $300.8 million, or 52.5%, from $573.3 million in fiscal 2024[16]. - Revenues for the three months ended January 31, 2025, were $232.474 million, a 41.3% increase from $164.554 million in the same period of 2024[30]. Profitability - Gross profit for Q4 2025 was $47.6 million, representing a gross margin of 20.5%, up from 14.4% in Q4 2024[9]. - Gross profit for the fiscal year ended January 31, 2025, was $140.989 million, compared to $80.834 million in 2024, reflecting a 74.5% increase[30]. - Net income for Q4 2025 reached $31.4 million, or $2.22 per diluted share, compared to $12.0 million, or $0.89 per diluted share, in the same quarter last year[12]. - The company recorded a net income of $85.5 million for fiscal 2025, or $6.15 per diluted share, compared to $32.4 million, or $2.39 per diluted share, in fiscal 2024[21]. - Net income for the three months ended January 31, 2025, was $31.369 million, up from $12.018 million in the prior year, representing a 161.5% increase[30]. EBITDA - EBITDA for Q4 2025 was $39.3 million, compared to $17.6 million in Q4 2024[12]. - EBITDA for the fiscal year ended January 31, 2025, was $113.500 million, significantly higher than $51.338 million in 2024, indicating a 121.5% growth[34]. Assets and Liabilities - Cash, cash equivalents, and investments totaled $525.1 million as of January 31, 2025, up from $412.4 million a year earlier[13]. - Total current assets increased to $781.300 million as of January 31, 2025, from $547.179 million in 2024, marking a 42.6% rise[32]. - Total liabilities rose to $484.370 million in 2025, compared to $307.290 million in 2024, reflecting a 57.6% increase[32]. - Cash and cash equivalents decreased to $145.263 million in 2025 from $197.032 million in 2024, a decline of 26.3%[32]. Expenses - Selling, general and administrative expenses for fiscal 2025 increased to $52.8 million, but as a percentage of revenues, they declined to 6.0% from 7.7% in the prior year[18]. Dividends and Shares - The company declared cash dividends per share of $0.375 for the three months ended January 31, 2025, up from $0.300 in the same period of 2024[30]. - Weighted average shares outstanding for diluted shares increased to 14.135 million in 2025 from 13.548 million in 2024[30]. Project Backlog - Project backlog grew to $1.4 billion as of January 31, 2025, including significant contracts for a 700 MW natural gas project in the U.S. and a 300 MW biofuel power plant in Ireland[5]. Comprehensive Income - Comprehensive income for the fiscal year ended January 31, 2025, was $82.518 million, compared to $31.637 million in 2024, an increase of 160.5%[30].